Abstracts tagged "ankylosing spondylitis (AS) and prognostic factors"

Abstract Number: 2476 • 2013 ACR/ARHP Annual Meeting
Periodontal Disease Is Not Associated With Ankylosing Spondylitis and TNF-Alpha Blockers Usage In Korea
Sung Hae Chang^1,2, Jung Tae Lee³, Byoung Youg Choi⁴, Hyon Joung Cho⁵, Jong Jin Yoo⁶, Hye Jin Oh⁷, Eun Ha Kang⁴, Yeong Wook Song^2,8, Hyo Jung Lee⁹ and Yun Jong Lee^2,10, ¹Internal Medicine Rheumatology, Seoul National University Bundang Hospital, Seongnam-si, South Korea, ²Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, ³Periodontology,Dentistry, Seoul National University Bundang Hospital, Seongnam-si, South Korea, ⁴Internal Medicine, Rheumatology, Seoul National University Bundang Hospital, Seongnam-si, South Korea, ⁵Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, ⁶Internal Medicine, Armed Forces Capital Hospital Seongnam Republic of Korea, Seongnam si, South Korea, ⁷Internal Medicine, Rheumatology, Seoul National University Hospital, Seoul, South Korea, ⁸Internal Medicine,Rheumatology, Seoul National University Hospital, Seoul, South Korea, ⁹Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam-si, South Korea, ¹⁰Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea
Background/Purpose: Periodontal disease (PD) is a chronic inflammatory disease, which has been reported to be associated with rheumatoid arthritis (RA). But, a few studies on…
Abstract Number: 2480 • 2013 ACR/ARHP Annual Meeting
Predicting Progression Of Non-Radiographic Axial Spondyloarthritis
Nigil Haroon^1,2,3, Lianne S. Gensler⁴, Dinny Wallis⁵, Ammepa Anton¹, Grace Yoon⁶ and Robert D. Inman⁷, ¹Rheumatology, University Health Network, Toronto, ON, Canada, ²Medicine, Rheumatology, University of Toronto, Toronto, ON, Canada, ³Toronto Western Research Institute, Toronto, ON, Canada, ⁴Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁵Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁶Medicine/Rheumatology, UCSF, San Franciscao, CA, ⁷Immunlogy and Institute of Medical Science, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: A proportion of patients with non-radiographic axial spondyloarthritis (NR-AxSpA) progress to AS but the predictors of progression have not been well established. We studied…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].